MedTrace Logo

Effect of IDEA-070 on Pain and Inflammation Induced by PDT

NCT00269074 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2009-03-20

No results posted yet for this study

Summary

Primary objectives: effect of IDEA-070 compared to placebo on pain and inflammation induced by PDT. The primary objective is to detect a statistically significant difference of pain and inflammation induced by PDT in test areas treated with IDEA-070 compared to placebo-treated areas.

Conditions

  • Actinic Keratosis

Interventions

DRUG

IDEA-070

Sponsors & Collaborators

  • IDEA AG

    lead INDUSTRY

Principal Investigators

  • Julia Reifenberger, PD Dr. med. · Dermatological department of university Duesseldorf

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2006-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00269074 on ClinicalTrials.gov